Franck Bruyere

Prof. Franck Bruyere


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Journal of Urology
Verified
Journal Article
Closed access
FBFranck Bruyere
Franck Bruyere
SMSandra Malavaud
Sandra Malavaud
PBPhilippe Bertrand
Philippe Bertrand
ADAliette Decock
Aliette Decock
GCGérard Cariou
Gérard Cariou
PCPatrick Coloby
Patrick Coloby
Prostate biopsy side effects have a role in the controversy over screening for prostate cancer. We measured the precise incidence of infection after prostate biopsy and determined risk factors. We performed a prospective, multicenter study in France from April to June 2013. All prostate biopsies done during this period were included in study. A web based questionnaire was used to identify patient characteristics, biopsy methods and postoperative infectious episodes. External audit helped ensure data completeness. The primary outcome was the post-biopsy infection rate. We determined risk factors for infectious complications using univariate and multivariate analysis. The study included 2,718 patients, of whom 6% reported receiving antibiotics in the previous 6 months and 7.4% had a history of prostatitis. Recommended antibiotic prophylaxis consisting of 2 fluoroquinolone tablets 2 hours before examination for prostate biopsy was noted in 78.3% of cases. Post-biopsy sepsis was found in 76 subjects (2.8%). On multivariate analysis predictors of post-biopsy sepsis were noncompliance with antibiotic prophylaxis guidelines (OR 2.3, 95% CI 1.4-3.9, p = 0.001), antibiotic treatment in the previous 6 months (OR 2.1, 95% CI 1.1-3.9, p = 0.015) and a history of prostatitis (OR 1.7, 95% CI 1.2-2.4, p = 0.002). In this study the incidence of post-prostate biopsy sepsis was 2.8% and no deaths were reported. Risk factors identified on multivariate analysis were noncompliance with antibiotic prophylaxis according to guidelines, antibiotic treatment in the previous 6 months and a history of prostatitis.

5 March 2018 in BJU International
Verified
Journal Article
Closed access
PDF file
BPBenoît Peyronnet
Benoît Peyronnet
LTLauranne Tondut
Lauranne Tondut
Jean-Christophe BERNHARDJean-Christophe BERNHARD
Jean-Christophe BERNHARD
CVChristophe Vaessen
Christophe Vaessen
NDNicolas Doumerc
Nicolas Doumerc
T(The members of the French Committee of Urologic Oncology (CCAFU)
The members of the French Committee of Urologic Oncology (CCAFU)

1 February 2010 in Progrès en Urologie
Verified
Journal Article
Closed access
FBFranck Bruyere
Franck Bruyere
ASAlbert Sotto
Albert Sotto
LEL. Escaravage
L. Escaravage
GCG. Cariou
G. Cariou
JMJ.-P. Mignard
J.-P. Mignard
HBH. Bugel
H. Bugel

1 January 2008 in Journal of Endourology
Verified
Journal Article
Closed access
FBFranck Bruyere
Franck Bruyere
CLCecile Leroux
Cecile Leroux
LBLaurent Brunereau
Laurent Brunereau
PLPatrick Lermusiaux
Patrick Lermusiaux
Purpose: Rapid prototyping is a technique used for creating computer images in three dimensions more efficiently than classic techniques. Percutaneous nephrolithotomy (PCNL) is a popular method to remove kidney stones; however, broader use by the urologic community has been hampered by the morbidity associated with needle puncture to gain access to the renal calix (bleeding, pneumothorax, hydrothorax, inadvertent colon injury). A training model to improve technique and understanding of renal anatomy could improve complications related to renal puncture; however, no model currently exists for resident training. Materials and Methods: We created a training model using the rapid prototyping technique based on abdominal CT images of a patient scheduled to undergo PCNL. This allowed our staff and residents to train on the model before performing the operation. This model allowed anticipation of particular difficulties inherent to the patient's anatomy. Results: After training, the procedure proceeded without complication, and the patient was discharged at postoperative day 1 without problems. Conclusions: We hypothesize that rapid prototyping could be useful for resident education, allowing the creation of numerous models for research and surgical training. In addition, we anticipate that experienced urologists could find this technique helpful in preparation for difficult PCNL operations.

31 October 2010 in Journal of Urology
Verified
Journal Article
Closed access
FBFranck Bruyere
Franck Bruyere
NCNiall Corcoran
Niall Corcoran
MMMarie-Noëlle Marson
Marie-Noëlle Marson
BDBenjamin Faivre D'Arcier
Benjamin Faivre D'Arcier
ACAnthony J. Costello
Anthony J. Costello
MOMarc Ohresser
Marc Ohresser
Purpose: Vascular endothelial cell growth factor is studied in different malignant tumors as a key endothelial cell mitogen. Many single nucleotide polymorphisms in the VEGF gene have been described. We compared VEGF gene polymorphisms between a control group and a renal cancer group. Materials and Methods: This study was performed in 202 control, white, healthy blood donors (control group) and in 51 consecutive patients with renal cell carcinoma. We studied VEGF genotype polymorphisms at positions −2549, −460, −1154, +405 and +936 using polymerase chain restriction fragment length polymorphism, and looked for correlations with clinical data. Results: No association was found between VEGF gene polymorphism and renal cell carcinoma prognostic parameters. However, in contrast as observed for controls and other polymorphisms the patient group displayed a heterozygote excess (p = 0.0179, 35.9% more than that expected) at the −460 polymorphism. Comparing the control group and the renal cell carcinoma group we detected a significantly increased risk of renal cell carcinoma in subjects with the C-460T polymorphism. T carrier genotypes and the T allele increased the risk of renal cell carcinoma with an OR of 14.15 (95% CI 1.900–105.41, p = 0.0017) and 2.14 (95% CI 1.34–3.419, p = 0.0018), respectively. The genotype at the −2549 polymorphism exhibited a nonsignificant trend for increased risk but the D allele was significantly associated with increased risk (p = 0.0305). Conclusions: Our results suggest that the −460 polymorphism is a risk factor for renal cancer. An individual screening test could be proposed for high risk populations.

Verified
Journal Article
Open access
PDF file
FBFanny Bery
Fanny Bery
SFSandy Figiel
Sandy Figiel
SKSana Kouba
Sana Kouba
DFDelphine Fontaine
Delphine Fontaine
Maxime F. GuéguinouMaxime F. Guéguinou
Maxime F. Guéguinou
KMKarine Mahéo
Karine Mahéo
Hypoxia is a well-established feature of prostate cancer (PCa) and is associated with disease aggressiveness. The hypoxic microenvironment initiates multiple adaptive responses including epithelial-to-mesenchymal transition (EMT) and a remodeling of calcium homeostasis involved in cancer progression. In the present study, we identified a new hypoxia signaling pathway with a positive feedback loop between the EMT transcription factor Zeb1 and SK3, a Ca2+-activated K+ channel, which leads to amplifying store-operated Ca2+ entry. Zeb1 and SK3 channel were strongly upregulated by hypoxia both in vitro and ex vivo in organotypic cultures of human PCa. Taking into account the sensitivity of the SK3 channel to the membrane lipid composition, we identified lipids such as Ohmline (an alkyl ether lipid and SK3 inhibitor), linoleic acid (LA) and eicosapentaenoic acid (EPA) (fatty acids associated with indolent PCa), which were able to completely abrogate the hypoxia-induced changes in Zeb1 expression. Ultimately, better understanding of this new hypoxia-induced EMT pathway may allow to develop adjuvant therapeutic strategies, in order to control PCa aggressiveness and improve treatment outcomes.